Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)

China flag China · Delayed Price · Currency is CNY
31.96
-0.41 (-1.27%)
Mar 11, 2026, 3:04 PM CST
17.16%
Market Cap 2.48B
Revenue (ttm) 252.77M
Net Income (ttm) 39.35M
Shares Out 76.49M
EPS (ttm) 0.51
PE Ratio 62.93
Forward PE n/a
Dividend 0.26 (0.80%)
Ex-Dividend Date May 29, 2025
Volume 1,490,500
Average Volume 1,243,599
Open 32.79
Previous Close 32.37
Day's Range 31.80 - 32.87
52-Week Range 22.83 - 36.98
Beta 0.65
RSI 60.64
Earnings Date Apr 29, 2026

About SHE:301130

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and capsules. The company was founded in 1990 and is headquartered in Panshi, China. [Read more]

Sector Healthcare
Founded 1990
Employees 320
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301130
Full Company Profile

Financial Performance

In 2024, SHE:301130's revenue was 256.41 million, an increase of 13.71% compared to the previous year's 225.49 million. Earnings were 40.27 million, a decrease of -20.26%.

Financial Statements

News

There is no news available yet.